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Lactotrophs are one of the five secretory anterior pituitary cell types specialized to synthe-
size and release prolactin. In vitro, these cells fire action potentials (APs) spontaneously
and the accompanied Ca2+ transients are of sufficient amplitude to keep the exocytotic
pathway, the transcription of prolactin gene, and de novo hormone synthesis continuously
active. Basal cyclic nucleotide production is also substantial in cultured cells but not critical
for the APs secretion/transcription coupling in lactotrophs. However, elevated intracellular
cAMP levels enhance the excitability of lactotrophs by stimulating the depolarizing non-
selective cationic hyperpolarization-activated cyclic nucleotide-regulated and background
channels, whereas cGMP inhibits it by activating Ca2+-controlled K+ channels. Elevated
cAMP also modulates prolactin release downstream of Ca2+ influx by changing the kinetic
of secretory pores: stimulate at low and inhibit at high concentrations. Induction of pro-
lactin gene and lactotroph proliferation is also stimulated by elevated cAMP through protein
kinase A.Together, these observations suggest that in lactotrophs cAMP exhibits complex
regulatory effects on voltage-gated Ca2+ influx and Ca2+-dependent cellular processes.
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INTRODUCTION
Lactotrophs are the anterior pituitary secretory cell type special-
ized to synthesize and release prolactin (PRL), a hormone with
roles in reproduction, lactation, and metabolism. Depending on
the sex and physiological status of the animals, lactotrophs com-
prise 20–50% of the cellular population of the anterior pituitary
gland and, as somatotrophs, they are organized in large-scale
networks (1–4). Ontogenetically, lactotrophs, together with soma-
totrophs and thyrotrophs, develop from the POU homeodomain
transcriptional factor Pit-1-dependent lineage of the pituitary
cells; Pit-1 is also necessary for the differentiation and proliferation
of these cells. Specific regions responsible for Pit-1 transcriptional
activity are found in the 5′ flanking region of PRL gene (Prl)
and Pit-1-dependent Prl induction can be modified by different
factors (5).
Lactotrophs are excitable cells and fire action potentials (APs)
spontaneously; the accompanied Ca2+ influx is of sufficient ampli-
tude to stimulate the exocytotic pathway by which prestored PRL
in secretory vesicles is released (6). Voltage-gated Ca2+ influx also
contributes to the control of other functions in pituitary cells,
including the induction of Prl (7–9) and control of cell prolifer-
ation (10, 11). Such spontaneous electrical activity is silenced by
numerous agonists, including dopamine, adenosine, endothelin-
1, gamma-amino butyric acid (GABA), neuropeptide Y, and 5-
HT, acting through Gi/o/z signaling pathway (12). In contrast,
vasoactive intestinal peptide (VIP) facilitates voltage-gated Ca2+
influx through Gs signaling pathway (13). In mammals, Ca2+-
mobilizing thyrotropin-releasing hormone (TRH), which comes
from the hypothalamus, is a well-recognized PRL-releasing factor.
Several other hypothalamic and intrapituitary agonists, including
oxytocin, vasopressin, angiotensin II, acetylcholine, ATP, sero-
tonin, and substance P, also stimulate PRL synthesis and release
by facilitating Ca2+ mobilization from intracellular stores (14).
It is now well established that cyclic nucleotides also play impor-
tant roles in lactotroph functions, a subject of this review. We
will first briefly discuss cyclic nucleotide signaling pathways in
pituitary cells: adenylyl cyclases (ACs), a family of enzymes that
synthesize cAMP from ATP; guanylyl cyclases (GCs), which are
responsible for production of cGMP from GTP; and phospho-
diesterases (PDEs) and cyclic nucleotide transporters, accounting
for control of intracellular cyclic nucleotide levels. This will be
followed by review of data on the role of cyclic nucleotides in
electrical activity, Ca2+ signaling, Prl expression, PRL synthesis
and secretion, and cell proliferation. We will discuss both direct
and indirect effects of cAMP and cGMP, mediated by cAMP-
dependent kinase (PKA) and cGMP-dependent kinase (PKG). For
the review of receptors modulating Ca2+ and cyclic nucleotide
signaling in lactotrophs see Stojilkovic et al. (12). For interactions
between intracellular calcium and cAMP in neuroendocrine cells
see Antoni (15, 16).
PITUITARY CYCLIC NUCLEOTIDES
The intracellular and extracellular cyclic nucleotide concentration
in pituitary cells reflects the status of cAMP and cGMP de novo pro-
duction and metabolism, the latter mediated by PDEs, a large fam-
ily of enzymes, some specific for cAMP or cGMP and others less
selective (3, 4). Pituitary cells express several PDEs (17, 18). In peri-
fused pituitary cells, 0.5 mM 3-isobutyl-1-methylxantine (IBMX),
a concentration that inhibits the majority of PDEs (19), increases
the release of both cyclic nucleotides, reaching the steady-state
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levels within 10–15 min of application (Figures 1A,B). In cultured
cells, IBMX induces a dose-dependent increase in cyclic nucleotide
release and intracellular cAMP (Figure 1D) and cGMP (Figure 1E)
accumulation. Although in both cases there is a linear relationship
between intra and extracellular cyclic nucleotide levels, there is
an obvious difference in the level of cAMP and cGMP intracellu-
lar accumulation; most of cGMP and only a fraction of cAMP is
released.
These simple experiments show that there is a substantial basal
cyclic nucleotide production in pituitary cells and that the intra-
cellular cyclic nucleotide concentration is not only controlled by
PDEs but also by the cyclic nucleotide export pump (20). This
pump has a preference for cGMP, which in turn limits the intra-
cellular cGMP accumulation and may represent an efficient way
for the pituitary cells to limit cGMP/PKG-dependent intracellular
signaling functions. Four lines of evidence indicate that multidrug
resistance proteins MRP4 and MRP5 account for cyclic nucleotide
transport in pituitary cells (21, 22): (i) the mRNA transcripts for
MRP4 and MRP5 are present in pituitary cells. (ii) The MRP5
protein is also present in pituitary cells. (iii) Down-regulation of
MRP5 expression in pituitary cells causes significant inhibition
of cyclic nucleotide transport. (iv) MK571, a relatively specific
inhibitor of MRPs, inhibits cyclic nucleotide transport in pituitary
cells (Figure 1J).
In perifused pituitary cells there is a substantial basal PRL
release, which further increases with IBMX-induced elevation
in cyclic nucleotide levels, and returns to basal levels after its
washout (Figure 1C). Such increase in PRL release is also observed
when de novo protein synthesis is blocked, indicating that cyclic
nucleotides affect the kinetics of basal PRL release from prestored
secretory vesicles. A comparison of intracellular cAMP levels and
PRL release suggests the bidirectional relationship: an increase
in PRL release at lower cAMP levels and a decrease at higher
cAMP levels (Figure 1F). In contrast, concentrations of intracel-
lular cGMP reached during IBMX treatment do not affect basal
PRL release (23).
FIGURE 1 | Characterization of cyclic nucleotide signaling pathways in
rat anterior pituitary cells in vitro. (A–C) Effect of IBMX, a PDEs inhibitor,
on cAMP (A), cGMP (B), and PRL (C) release by perifused pituitary cells.
(D,E) Correlation between released and cell content cAMP (D) and cGMP
(E) in cells in static cultures treated with variable concentrations of IBMX. R,
coefficient of correlation. (F)The relationship between cAMP intracellular
content and PRL release. (G–I) Effects of forskolin, an AC activator, on cAMP
(G), cGMP (H), and PRL (I) release by perifused pituitary cells. (J) Effect of
MK571, an inhibitor of MRP transporters, on cAMP release in perifused
pituitary cells. (K) Correlation between NO levels and cGMP production in
cells stimulated with increasing doses of DPTA, an NO donor. (L) Stimulation
of basal PRL release with 8-Br-cAMP but not with 8-pCPT-2Me-cAMP, an Epac
cAMP receptor agonist. Gray areas indicate the duration of application of
drugs.
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Pituitary cells express several subtypes of ACs (24), includ-
ing the Ca2+-inhibitable forms (23), but investigations of the cell
type-specific expression of these enzymes have not been done.
Figure 1A shows that pituitary ACs exhibit considerable basal
activity. This is further confirmed by the inhibition of basal
cAMP production with AC inhibitors (23). In lactotrophs, basal
AC activity is inhibited by Gi/o/z-coupled receptors activated by
adenosine, dopamine, endothelin, GABA, neuropeptide Y, and 5-
HT receptors, and is facilitated by the Gs-coupled VIP/pituitary
adenylate cyclase-activating peptide (PACAP) receptors (12). Both
cAMP and cGMP release in perifused pituitary cells are stimu-
lated by forskolin, a common activator of AC1–AC8 (Figures 1G,
H). Similarly to IBMX, forskolin alone induces PRL release in a
time-dependent manner (Figure 1I).
Pituitary cells also express the particulate (25, 26) and soluble
GCs (27) responsible for synthesis of cGMP. It appears that the
α1β1 soluble GC dimer is expressed in the anterior pituitary cells
and accounts for the nitric oxide (NO)-dependent facilitation of
cGMP production. Lactotrophs express NO synthases (NOS), a
family of enzymes responsible for generation of NO and acti-
vation of soluble GC. Two calcium-sensitive NOS, endothelial
and neuronal, are found in pituitary tissue and mixed cultured
cells, as well as in enriched lactotroph and somatotroph fractions.
Calcium-independent inducible NOS are also expressed in cul-
tured lactotrophs and somatotrophs but only transiently, probably
reflecting the influence of mechanical and enzymatic factors dur-
ing dispersion of cells from intact tissue on the status of these
enzymes (27). The G protein-coupled receptors contribute to
the regulation of soluble GC activity in a Ca2+-dependent and
-independent manner (28); the Ca2+-independent stimulation of
the enzyme activity by Gs-coupled receptors is mediated by PKA-
dependent phosphorylation of the α subunit (29). This explains
effects of forskolin on cGMP release (Figure 1H).
The NO dependence of cGMP production in pituitary cells
is shown in experiments with DPTA, an NO donor (Figure 1K)
(29). The activation of soluble GC is accompanied with inhibition
rather than stimulation of PRL release in cultured pituitary cells,
largely reflecting the cGMP-independent effects of NO on PRL
release through a mechanism still not characterized (30). Appli-
cation of 8-Br-cGMP, a cell-permeable cGMP analog, is unable
to modulate PRL release. However, application of 8-Br-cAMP, a
cell-permeable cAMP analog, mimics the effects of IBMX, and
forskolin on PRL release (23), clearly indicating that elevation in
cAMP but not cGMP levels facilitates the exocytotic pathways in
these cells. This action is not mediated by Epac cAMP receptor, as
application of 8pCPT-2Me-cAMP does not mimic the effects of
8-Br-cAMP on PRL release (Figure 1L).
ROLES OF CYCLIC NUCLEOTIDES IN EXCITABILITY OF
LACTOTROPHS
In vitro, isolated lactotrophs generate APs independently of exter-
nal stimuli, a phenomenon termed spontaneous electrical activity.
Both types of electrical activity, single spiking and plateau burst-
ing, are observed (12); the latter type being generator of global
Ca2+ transients (Figure 2A). The physiological significance of
such spontaneous electrical activity in lactotrophs is now well
established. The cells in vitro release PRL in the absence of external
stimuli termed basal or spontaneous release (14). High PRL release
is also observed in animals bearing ectopic pituitary grafts (31).
In both cases, spontaneous APs and the associated Ca2+ influx
account for high steady-state PRL release and any maneuver lead-
ing to silencing of electrical activity also abolishes Ca2+ influx and
basal PRL release (32). Continuous PRL release does not affect
the intracellular PRL pool significantly in perifused pituitary cells,
because basal Prl expression is sufficient to keep de novo hormone
synthesis (33) in part due to role of Ca2+ in induction of this
gene (9).
Spontaneous firing of APs and basal PRL secretion are not crit-
ically dependent on the status of intracellular cyclic nucleotides;
inhibition of basal AC activity decreases but does not abolish basal
PRL release and has no effect on spontaneous firing of APs. Inhibi-
tion of NOS and soluble GC is also ineffective, as well as inhibition
of PKA and PKG (23). Thus, spontaneous firing of APs is an intrin-
sic feature of lactotrophs and, at least in a fraction of lactotrophs,
firing of AP accounts for basal PRL release.
The hypothalamic dopamine, acting through dopamine D2
receptors, is the main physiological inhibitor of spontaneous elec-
trical activity and the coupled synthesis and release of PRL (34).
Figure 2A shows a rapid effect of a D2 receptor agonist on spon-
taneous electrical activity and voltage-gated Ca2+ influx. Both
dopamine and endothelin-1 also inhibit firing of AP and PRL
release in cells with elevated cAMP, indicating that these agonists
utilize other pathways to silence lactotrophs (33, 35). These include
activation of inwardly rectifying K+ channels and inhibition of
voltage-gated Ca2+ channels, causing abolition of electrical activ-
ity and basal PRL secretion independently of the status of AC
activity (33, 34).
However, elevation of intracellular cAMP levels stimulates elec-
trical activity in quiescent cells and increases the AP frequency in
spontaneously firing cells (23, 36); Figure 2B illustrates effects
of forskolin and Figure 2C effects of 8-Br-cAMP on initiation
of firing of AP, whereas Figure 2D shows increase in the fre-
quency of spiking in a spontaneously active cell. Such stimula-
tion occurs both in a PKA-independent and -dependent manner.
The PKA-independent facilitation of electrical activity probably
involves direct effects of cAMP on hyperpolarization-activated
cyclic nucleotide-regulated (HCN) channels, which are expressed
in GH3 lacto-somatotrophs and in a fraction of lactotrophs (22, 37,
38) and are inhibited by 1 mM Cs+ in bath medium (Figure 2E).
Figure 2D shows the PKA-dependent facilitation of electrical
activity; inhibition of PKA by Rp-cAMPs eliminates an increase in
the firing frequency generated by 8-Br-AMP, but does not abolish
spontaneous electrical activity. The channels responsible for PKA-
dependent facilitation of electrical activity in lactotrophs have not
been identified, but several recent findings indicate that phospho-
rylation of a putative Na+-dependent background (Nab) channels
may account for it. The expression of this channel in lactotrophs
and immortalized GH3 lacto-somatotrophs was originally pro-
posed by Simasko’s group (39, 40) using a protocol shown in
Figures 2F–I. Replacement of extracellular Na+ with NMDG,
a large organic cation, causes an instantaneous hyperpolariza-
tion of cell membrane and abolition of spontaneous AP firing
(Figure 2F), indicating the dependence of the baseline membrane
potential on Nab conductance. Voltage-gated Na
+ channels do
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FIGURE 2 | Electrical activity and Ca2+ signaling in pituitary
lactotrophs in vitro. (A) Simultaneous measurements of effects of
apomorphine, a D2 receptor agonist, on spontaneous firing of APs (top)
and Ca2+ signaling (bottom). (B,C) Effects of forskolin, an activator of ACs
(B), and 8-Br-cAMP, a cell-permeable cAMP analog (C), on electrical
activity of lactotrophs. (D) Effects of 8-Br-cAMP and Rp-cAMPs, a PKA
inhibitor, on the frequency of APs in spontaneously firing lactotrophs.
(E)Whole-cell voltage-clamp recording of Ih in the presence (gray) and
absence (green) of 1 mM Cs+, an inhibitor of HCN channels. (F,G) Effects
of complete replacement of bath Na+ with NMDG (F) and addition of
tetrodotoxin (TTX) (G) on electrical activity in lactotrophs. (H) Effects of
complete replacement of bath Na+ with NMDG on spontaneous Ca2+
signaling in lactotrophs. (I) Effects of complete replacement of bath Na+
with NMDG, choline chloride, and TMA on basal PRL release.
(J) Schematic representation of effects of intracellular Ca2+ and cAMP on
lactotroph function.
not account for this conductance, because tetrodotoxin, a specific
blocker of these channels, does not abolish spontaneous firing
of APs (Figure 2G). In intact cells, replacement of bath Na+
with NMDG+ abolishes spontaneous Ca2+ spiking (Figure 2H).
Basal PRL release is also abolished by replacement of bath Na+
with NMDG+ and other large cations (Figure 2I). The Nab con-
ductance was also reduced in lactotrophs with various inhibitors
of cation channels, including TRP channels, causing cessation of
electrical activity and inhibition of PRL release (41). This could
indicate that a member of TRP family of channels accounts for the
Nab conductance in lactotrophs and other secretory pituitary cell
types (42).
Numerous experiments performed with normal rat and mouse
pituitary cells, as well as in pituitary cells haploinsufficient for
the main PKA catalytic subunit, are consistent with a hypothe-
sis that Nab channels are stimulated by PKA and contribute to
Ca2+ signaling and basal PRL release indirectly, by controlling the
pacemaking depolarization (42). It also appears that the MRP4/5-
mediated cyclic nucleotide efflux can be rapidly modulated by
membrane potential of anterior pituitary cells determined by Nab
conductance (22). At the present time, it is not clear what is
the mechanism and physiological role of regulation of MRP4/5
activity by membrane potential.
In contrast to cAMP, cGMP is unlikely to play an important role
in control of lactotroph functions. This could reflect the preference
of MRP4/5 for cGMP, not allowing substantial intracellular accu-
mulation of this second messenger. Still, it is possible that cGMP
inhibits spontaneous excitability of lactotrophs by activating the
BK-type of Ca2+-controlled K+ channels in a PKG-dependent
manner (20). The presence of NOS signaling system in these cells
may provide an additional and cGMP-independent mechanism
for inhibition of PRL secretion (30).
EFFECTS OF CAMP ON PRL RELEASE DOWNSTREAM OF Ca2+
INFLUX
Both cAMP and its kinase also play important roles in the con-
trol of pituitary cell functions independently of Ca2+ signaling.
This includes stimulation of the exocytotic pathway downstream
of the voltage-gated Ca2+ influx (43). Recently, we clarified
the mechanism by which cAMP at high concentrations inhibits
PRL release. By using high-resolution capacitance measurements,
which represent elementary exocytotic events, increase in the
frequency of transient exocytotic events was detected. Basically,
cAMP mediated stabilization of wide fusion pores prevents secre-
tory vesicles in lactotrophs from proceeding to the full-fusion
stage of exocytosis, which hinders vesicle content discharge at
high cAMP concentrations (44). Further investigations are needed
to separate direct effects of cAMP from those mediated by PKA
on the exocytotic pathway in lactotrophs downstream of Ca2+
influx.
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OTHER ROLES OF CYCLIC NUCLEOTIDES IN LACTOTROPHS
Prl transcription is regulated by cAMP through PKA signal-
ing pathway (45) in a cAMP response element-binding protein-
independent manner (46). It has also been shown that Gs
alpha subunits stimulate Pit-1 promoter via a PKA-mediated
signaling pathway (47). PACAP also facilitates Prl expres-
sion in immortalized lacto-somatotrophs in a PKA-dependent
manner, in contrast to TRH, which facilitates transcription
in a Ca2+-dependent manner (48). Furthermore, there is a
PKA-dependent but Pit-1-independent effect of cAMP on Prl
expression (49).
cAMP and PKA contribute to the control of lactotroph pro-
liferation. Down-regulation of basal AC by dopamine is known
to inhibit not only Prl expression but also lactotroph prolifera-
tion (50). It appears that the cAMP-dependent cell proliferation
requires the MAPK signaling pathway (51). It has been suggested
that the cAMP response element-binding protein is involved in the
regulation of cell proliferation and Prl expression in normal lac-
totrophs (52). VIP also facilitates lactotroph proliferation through
MAPK signaling pathway (53).
SUMMARY
The interactions between Ca2+ and cAMP in control of lactotroph
functions are summarized in Figure 2J. Spontaneous electrical
activity and AP secretion coupling are sufficient to keep lac-
totrophs operative in the absence of any stimuli due to refilling
of the PRL secretory pool by Ca2+-dependent Prl expression and
de novo protein synthesis. AP-driven Ca2+ influx controls basal
cAMP levels by inhibiting AC5/6 isoforms and stimulating PDEs.
Still the residual cAMP levels are sufficient to integrate HCN
channels in spontaneous electrical activity and probably to facil-
itate exocytosis downstream of voltage-gated Ca2+ influx. Ca2+
signaling function in lactotrophs is facilitated by numerous Ca2+-
mobilizing receptors expressed in these cells, and their activation
transiently inhibits electrical activity, followed by a sustained
increase in the firing frequency. Detailed studies are needed to
clarify whether and how many of these receptors cross-couple to
the Gs signaling pathway. Experiments with IBMX, forskolin, and
cell-permeable cAMP analogs show that cAMP directly stimulates
HCN channels and through PKA stimulates still unidentified Nab
channels, and probably influences gating of several other chan-
nels. The cAMP-dependent modulation of PRL release reflects the
effects of this messenger on excitability of lactotrophs, the accom-
panied voltage-gated Ca2+ influx and Ca2+-dependent exocytosis
of the prestored PRL, as well as its influence on the exocytotic
pathway downstream of voltage-gated Ca2+ influx. cAMP exhibits
bidirectional effects on the kinetics of secretory pores, by facilitat-
ing it at lower concentrations and stabilizing it at higher con-
centrations. Further studies are needed to clarify to which extent
cAMP, PKA, or Epac cAMP receptors contribute to this process.
The AC-signaling pathway provides a very powerful pathway for
stimulation of electrical activity, cell proliferation, Prl expression,
and exocytosis. However, only VIP and PACAP use this pathway
to stimulate lactotroph function by activating VPAC2 receptors
coupled to the Gs signaling pathway. In contrast, at least six Gi/o/z-
coupled receptors activated by adenosine, dopamine, endothelin-
1, GABA, neuropeptide Y, and 5-HT, silence both AC activity and
spontaneous electrical activity, clearly indicating that the main role
of hypothalamic and intrapituitary regulation is to slow down this
runaway engine.
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